CLINICAL TRIAL PATIENT TECHNOLOGY INSIGHTS
-
![GettyImages-1308685498]( "When The System Breaks, Who Pays? SCRS On Site Tech Gaps")
When The System Breaks, Who Pays? SCRS On Site Tech GapsSCRS CSSO Jimmy Bechtel on why clinical site tech integration is an architecture problem – and who bears the risk when remote systems fail.
-
![scientist in a modern laboratory studies human body with HUD, graphic display-GettyImages-1396802026]( "HTA, Digital Twins, And Building Clinical Tech That Lasts")
HTA, Digital Twins, And Building Clinical Tech That LastsISPOR CEO Rob Abbott on HTA-integrated trial design, digital twin evidence gaps, SaMD’s continuous update problem, and the one change he’d mandate for clinical tech.
ECOA RESOURCES
-
![Security Technology MSP]( "Building Patient-Focused eCOA Strategies: Insights And Best Practices")
Discover why the use of electronic clinical outcome assessments (eCOA) in clinical research is becoming an increasingly important part of study design in this article.
-
![From 3 meetings to 1]( "From 3 Meetings To 1: Remove Bottlenecks With AI-Enabled eCOA")
Learn how AI-enabled eCOA can reduce complexity in trial setup by cutting unnecessary meetings, speeding execution, and helping teams focus on what matters most.
-
![GettyImages-1142528978 digital healthcare]( "Embracing Accessibility: The Future Of Clinical Trials")
Explore the reasons why accessibility stands as a crucial pillar for the prosperity of biopharmaceutical and clinical research, having evolved into an all-encompassing industry imperative.
ECONSENT RESOURCES
-
![GettyImages-2153183419-digital-signature-eConsent]( "The Catch-22 Of eConsent: A Missed Opportunity For Improved Trials")
Drawing on evidence from scientific literature, we examine the pitfalls that have hindered its success and propose actionable solutions to unlock its true value in clinical research.
-
![GettyImages-1314299046 econsent]( "Preparing Studies With eConsent For IRB Approval")
Understand how eConsent can benefit trials and align with IRB ethical commitments, how to prepare your IRB submission for approval, and the future impact of large language models.
-
![total_consent_adoption_feb_22_presentation_rev]( "Everything You Need To Know About Adopting eConsent Across Large Pharma Organizations")
Did you know that the average cost for a delayed trial is between $600,000 and $8 million per day? Discover how electronic consent management technology is helping sponsors, CROs, and sites.
EPRO RESOURCES
-
![GettyImages-1166419449 laptop and book vector]( "Electronic Hauser Diary For Parkinson's Clinical Trials")
In honor of World Movement Disorders Day, we highlight advances in Parkinson’s disease care. At the 2024 MDS Congress, Signant presented research on electronic diaries for tracking PD patients' functional status.
-
![veeva clinical platform thumb]( "End-To-End Clinical Data Flow")
Explore the interconnected data flow across Veeva Vault EDC, Veeva CDB, Veeva RTSM, and Veeva ePRO to visualize how these products work together seamlessly.
-
![veeva rethinking epro thumb]( "Rethinking Today's ePRO Delivery For Tomorrow's Clinical Trials")
Willie Muehlhausen, Co-CEO and Founder of Safira Clinical Research, and Tim Davis, VP of Strategy at MyVeeva for Patients, discuss how ePRO delivery needs to change to better serve modern trials.
